… sarcomas, renal cell carcinoma, mesothelioma, gastric, and gliomas/ … s ongoing phase 2b clinical trial for GBM and encouraging … the participation in this clinical trial. About BPM31510-IV … several in late-stage clinical trials. BPGbio’s novel approach …

… clinical trial evaluating TT-4, Cyncado’s selective A2B receptor antagonist, in mesothelioma … investigator-initiated clinical trial of TT-4 in mesothelioma in Australia … and implementing the Australian trial; clinical trial outcomes and regulatory approvals; …

… Thoracic Oncology and Phase I Clinical Trials Multidisciplinary Teams (MDT). He … treating esophageal cancer, lung cancer, mesothelioma, thymoma, and thymic carcinoma. His … research fellowship in precision oncology clinical trials at Eleanor N. Dana Cancer …

… and attend the 2025 International Mesothelioma Interest Group (iMig) Conference … clinical trials, as well as discussions on prevention and early detection of mesothelioma … proudly-sponsors-the-2025-international-mesothelioma-interest-group-imig-conference- …

… simulations to help inform upcoming mesothelioma clinical trials at Cyncado Therapeutics, a wholly … -specific financing to support focused clinical trials under clear governance and ring …

… as ctDNA, with clinical outcomes. Diffuse pleural mesothelioma is a rare, … . “This is the first published clinical trial to show that perioperative combination … but potentially beneficial in resectable mesothelioma,” says Valsamo “Elsa” Anagnostou, M …

… Injection Means for Mesothelioma Patients For patients with mesothelioma, the new … treatment. Maintains treatment effectiveness: Clinical trials show that the new injection … for multiple rounds: Many mesothelioma patients require repeated treatments. The …

…  both epithelial and non-epithelioid mesothelioma models Quantified anti-tumor activity … to finalize clinical development plans for TT-4 in mesothelioma, with first … but not limited to: regarding clinical trial outcomes and regulatory approvals; uncertainty …

… in-human evaluation. In human mesothelioma spheroid systems, hypoxia-linked … monotherapy activity in an immunocompetent mesothelioma model, and combination treatment … but not limited to: regarding clinical trial outcomes and regulatory approvals; uncertainty …

… In an immunocompetent in vivo mesothelioma model, TT-4 monotherapy outperformed … with an initial focus on mesothelioma, advancing toward first-patient dosing … not limited to: uncertainty regarding clinical trial outcomes and regulatory approvals; uncertainty …